Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
The American Journal of Psychiatry
|
January 5, 2021
A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder
Adriana Feder, Sara Costi, Sarah B Rutter, et al.
Focus (American Psychiatric Publishing)
|
July 5, 2023
A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder
Adriana Feder, Sara Costi, Sarah B Rutter, et al.
Translational Psychiatry
|
November 6, 2021
Peripheral immune cell reactivity and neural response to reward in patients with depression and anhedonia
Sara Costi, Laurel S Morris, Abigail Collins, et al.
Molecular Psychiatry
|
November 3, 2018
Effects of the KCNQ channel opener ezogabine on functional connectivity of the ventral striatum and clinical symptoms in patients with major depressive disorder
Aaron Tan, Sara Costi, Laurel S Morris, et al.
The Journal of Clinical Psychiatry
|
April 11, 2025
Combining Ketamine Infusions and Written Exposure Therapy for Chronic PTSD: An Open-Label Trial
Adriana Feder, Oneysha Brown, Sarah B Rutter, et al.
JAMA Network Open
|
June 25, 2024
Ketamine vs Electroconvulsive Therapy for Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial
Manish Kumar Jha, Samuel T Wilkinson, Kamini Krishnan, et al.
The American Journal of Psychiatry
|
March 3, 2021
Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial
Sara Costi, Laurel S Morris, Katherine A Kirkwood, et al.
The New England Journal of Medicine
|
May 24, 2023
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
Amit Anand, Sanjay J Mathew, Gerard Sanacora, et al.
Research Square
|
February 13, 2023
Peripheral immune-derived matrix metalloproteinase promotes stress susceptibility
Flurin Cathomas, Hsiao-Yun Lin, Kenny L Chan, et al.
Nature
|
February 7, 2024
Circulating myeloid-derived MMP8 in stress susceptibility and depression
Flurin Cathomas, Hsiao-Yun Lin, Kenny L Chan, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
The American Journal of Psychiatry
|
January 5, 2021
A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder
Adriana Feder, Sara Costi, Sarah B Rutter, et al.
Focus (American Psychiatric Publishing)
|
July 5, 2023
A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder
Adriana Feder, Sara Costi, Sarah B Rutter, et al.
Translational Psychiatry
|
November 6, 2021
Peripheral immune cell reactivity and neural response to reward in patients with depression and anhedonia
Sara Costi, Laurel S Morris, Abigail Collins, et al.
Molecular Psychiatry
|
November 3, 2018
Effects of the KCNQ channel opener ezogabine on functional connectivity of the ventral striatum and clinical symptoms in patients with major depressive disorder
Aaron Tan, Sara Costi, Laurel S Morris, et al.
The Journal of Clinical Psychiatry
|
April 11, 2025
Combining Ketamine Infusions and Written Exposure Therapy for Chronic PTSD: An Open-Label Trial
Adriana Feder, Oneysha Brown, Sarah B Rutter, et al.
JAMA Network Open
|
June 25, 2024
Ketamine vs Electroconvulsive Therapy for Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial
Manish Kumar Jha, Samuel T Wilkinson, Kamini Krishnan, et al.
The American Journal of Psychiatry
|
March 3, 2021
Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial
Sara Costi, Laurel S Morris, Katherine A Kirkwood, et al.
The New England Journal of Medicine
|
May 24, 2023
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
Amit Anand, Sanjay J Mathew, Gerard Sanacora, et al.
Research Square
|
February 13, 2023
Peripheral immune-derived matrix metalloproteinase promotes stress susceptibility
Flurin Cathomas, Hsiao-Yun Lin, Kenny L Chan, et al.
Nature
|
February 7, 2024
Circulating myeloid-derived MMP8 in stress susceptibility and depression
Flurin Cathomas, Hsiao-Yun Lin, Kenny L Chan, et al.
Page
of 3